{
  "type": "hyp",
  "text": "Analysis of the gene expression profile of the p53-transcriptional targets showed distinct features between chlorambucil Nutlin-3 and fludarabine which likely account for their differential effect on cell cycle in SKW6.4 cells. Of note all agonists upregulated TRAIL-R2 expression in SKW6.4 cells both at the mRNA and protein levels.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "Analysis",
        "the gene expression profile",
        "the p53-transcriptional targets",
        "distinct features",
        "chlorambucil Nutlin-3",
        "fludarabine",
        "their differential effect",
        "cell cycle",
        "SKW6.4 cells",
        "Of note",
        "all agonists",
        "upregulated TRAIL-R2 expression",
        "SKW6.4 cells",
        "the mRNA and protein levels"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What showed distinct features between chlorambucil Nutlin-3 and fludara",
          "What did the analysis of p53-transcriptional targets show?",
          "What gene expression profile did analysis of?",
          "What did the analysis of the gene expression profile of the p53-transcriptional targets",
          "What agonist upregulated TRAIL-R2 expression in SKW6.4 cells?",
          "What agonist upregulated TRAIL-R2 expression in SKW6.4 cells?",
          "What is likely to be attributed to the differences in the cell cycle?",
          "What did the differences in agonists explain?",
          "What cells did the agonists upregulate TRAIL-R2 expression?",
          "What is the effect of agonists on TRAIL-R2 expression?",
          "What upregulated TRAIL-R2 expression in SKW6.4 cells?",
          "What did the agonists do?",
          "What cells did the agonists upregulate TRAIL-R2 expression?",
          "What two levels of TRAIL-R2 expression did the agonists upreg"
        ]
      }
    }
  },
  "asked": {
    "What showed distinct features between chlorambucil Nutlin-3 and fludara": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Analysis of the gene expression profile of the p53-transcriptional targets",
        "answerability": 0.9472708702087402,
        "ground_truth": {
          "Analysis": {
            "bertscore": 0.6595320105552673,
            "f1": 0.2222222222222222
          }
        }
      }
    },
    "What did the analysis of p53-transcriptional targets show?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "distinct features between chlorambucil Nutlin-3 and fludarabine",
        "answerability": 0.983472466468811,
        "ground_truth": {
          "the gene expression profile": {
            "bertscore": 0.6375666260719299,
            "f1": 0
          }
        }
      }
    },
    "What gene expression profile did analysis of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "p53-transcriptional targets",
        "answerability": 0.9867833256721497,
        "ground_truth": {
          "the p53-transcriptional targets": {
            "bertscore": 0.93751460313797,
            "f1": 1.0
          }
        }
      }
    },
    "What did the analysis of the gene expression profile of the p53-transcriptional targets": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.4855723977088928,
        "ground_truth": {
          "distinct features": {
            "bertscore": 0.7141565680503845,
            "f1": 0
          }
        }
      }
    },
    "What agonist upregulated TRAIL-R2 expression in SKW6.4 cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "all",
        "answerability": 0.8211617469787598,
        "ground_truth": {
          "chlorambucil Nutlin-3": {
            "bertscore": 0.5727773308753967,
            "f1": 0
          },
          "fludarabine": {
            "bertscore": 0.6441550850868225,
            "f1": 0
          }
        }
      }
    },
    "What is likely to be attributed to the differences in the cell cycle?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "their differential effect",
        "answerability": 0.9071311950683594,
        "ground_truth": {
          "their differential effect": {
            "bertscore": 1.000000238418579,
            "f1": 1.0
          }
        }
      }
    },
    "What did the differences in agonists explain?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "likely account for their differential effect on cell cycle in SKW6.4 cells",
        "answerability": 0.9617801904678345,
        "ground_truth": {
          "cell cycle": {
            "bertscore": 0.6551229953765869,
            "f1": 0.2857142857142857
          }
        }
      }
    },
    "What cells did the agonists upregulate TRAIL-R2 expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "SKW6.4 cells",
        "answerability": 0.9961665272712708,
        "ground_truth": {
          "SKW6.4 cells": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What is the effect of agonists on TRAIL-R2 expression?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "upregulated",
        "answerability": 0.9940893054008484,
        "ground_truth": {
          "Of note": {
            "bertscore": 0.732384204864502,
            "f1": 0
          }
        }
      }
    },
    "What upregulated TRAIL-R2 expression in SKW6.4 cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "all agonists",
        "answerability": 0.9745874404907227,
        "ground_truth": {
          "all agonists": {
            "bertscore": 0.9999995231628418,
            "f1": 1.0
          }
        }
      }
    },
    "What did the agonists do?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "upregulated TRAIL-R2 expression",
        "answerability": 0.9546351432800293,
        "ground_truth": {
          "upregulated TRAIL-R2 expression": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "What two levels of TRAIL-R2 expression did the agonists upreg": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "mRNA and protein levels",
        "answerability": 0.9352771639823914,
        "ground_truth": {
          "the mRNA and protein levels": {
            "bertscore": 0.9368720650672913,
            "f1": 1.0
          }
        }
      }
    }
  }
}